Myovant Sciences Valuation
| MYOVDelisted Stock | USD 26.98 0.01 0.04% |
At this time, the firm appears to be overvalued. Myovant Sciences secures a last-minute Real Value of $22.9 per share. The latest price of the firm is $26.98. Our model forecasts the value of Myovant Sciences from analyzing the firm fundamentals such as Operating Margin of (0.39) %, return on asset of -0.18, and Shares Outstanding of 97.26 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend buying undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Myovant Sciences' price fluctuation is very steady at this time. Calculation of the real value of Myovant Sciences is based on 3 months time horizon. Increasing Myovant Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Myovant Sciences is useful when determining the fair value of the Myovant stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Myovant Sciences. Since Myovant Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Myovant Stock. However, Myovant Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 26.98 | Real 22.9 | Hype 26.98 |
The real value of Myovant Stock, also known as its intrinsic value, is the underlying worth of Myovant Sciences Company, which is reflected in its stock price. It is based on Myovant Sciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Myovant Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Myovant Sciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Myovant Sciences helps investors to forecast how Myovant stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Myovant Sciences more accurately as focusing exclusively on Myovant Sciences' fundamentals will not take into account other important factors: Myovant Sciences Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Myovant Sciences's current stock value. Our valuation model uses many indicators to compare Myovant Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Myovant Sciences competition to find correlations between indicators driving Myovant Sciences's intrinsic value. More Info.Myovant Sciences is considered to be number one stock in price to earning category among related companies. It is considered to be number one stock in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Myovant Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Myovant Sciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Myovant Sciences' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Myovant Sciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Myovant Sciences and how it compares across the competition.
About Myovant Sciences Valuation
The delisted stock valuation mechanism determines the current worth of Myovant Sciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Myovant Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Myovant Sciences based exclusively on its fundamental and basic technical indicators. By analyzing Myovant Sciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Myovant Sciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Myovant Sciences. We calculate exposure to Myovant Sciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Myovant Sciences's related companies.Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. Myovant Sciences Ltd. is a subsidiary of Sumitovant Biopharma Ltd. Myovant Sciences operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 579 people.
8 Steps to conduct Myovant Sciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Myovant Sciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Myovant Sciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Myovant Sciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Myovant Sciences' revenue streams: Identify Myovant Sciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Myovant Sciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Myovant Sciences' growth potential: Evaluate Myovant Sciences' management, business model, and growth potential.
- Determine Myovant Sciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Myovant Sciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Myovant Sciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Myovant Sciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 93 M | |
| Retained Earnings | -1.3 B | |
| Retained Earnings Total Equity | -1.3 B |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Myovant Stock
If you are still planning to invest in Myovant Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Myovant Sciences' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |